Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 2/20 | 0.41 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | BHMT | Q93088 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ritiometan SCHEMBL867253 | 0.83 | CYP2C19 (0.53) | CYP2C19CYP2D6HIF1AALKBH5PHGDH | |
| SCHEMBL8030361 | 0.75 | CYP2D6 (0.45) | CYP2C19CYP2D6HIF1AALKBH5PHGDH | |
| SCHEMBL589940 | 0.75 | — | — | |
| SCHEMBL4655762 | 0.75 | — | — | |
| SCHEMBL9811047 | 0.73 | — | — | |
| SCHEMBL23931412 | 0.71 | BHMT (0.42) | CYP2C19CYP2D6HIF1AALKBH5PHGDH | |
| SCHEMBL9619629 | 0.71 | — | — | |
| SCHEMBL8998014 | 0.71 | CYP2D6 (0.41) | CYP2C19CYP2D6HIF1AALKBH5PHGDH | |
| SCHEMBL2808412 | 0.71 | BHMT (0.42) | CYP2C19CYP2D6HIF1AALKBH5PHGDH | |
| SCHEMBL28862415 | 0.71 | CYP2D6 (0.41) | CYP2C19CYP2D6HIF1AALKBH5PHGDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113563759-A | Graphene and nano-silver composite material and preparation method thereof | 中国科学院山西煤炭化学研究所 | 2021-10-29 | — | — | CN | claimed |
| US-8569197-B2 | Process for preparing a reforming catalyst comprising a support, a group VIIIB metal and a group VIIB metal | IFP Energies Nouvelles (FR) | 2013-10-29 | — | — | US | claimed |
| EP-2222399-B1 | METHOD FOR PREPARING A REFORMING CATALYST INCLUDING A SUBSTRATE, A METAL OF GROUP VIII AND A METAL OF GROUP VIIB | IFP Energies Nouvelles (FR) | 2013-09-18 | — | — | EP | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-20090143224-A1 | PROCESS FOR PREPARING A REFORMING CATALYST COMPRISING A SUPPORT, A GROUP VIIIB METAL AND A GROUP VIIB METAL | IFP (FR) | 2009-06-04 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20240218141-A1 | ORGANIC POLYMER AEROGELS COMPRISING MICROSTRUCTURES | Blueshift Materials, Inc. | 2024-07-04 | — | — | US | disclosed |
| EP-3529301-B1 | FIBER-REINFORCED ORGANIC POLYMER AEROGEL | BLUESHIFT MAT INC (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11814497-B2 | Organic polymer aerogels comprising microstructures | Blueshift Materials, Inc. (US) | 2023-11-14 | — | — | US | disclosed |
| US-11345792-B2 | Fiber-reinforced organic polymer aerogel | Blueshift Materials, Inc. (US) | 2022-05-31 | — | — | US | disclosed |
| US-11192993-B2 | Organic polymer aerogels comprising microstructures | Blueshift Materials, Inc. (US) | 2021-12-07 | — | — | US | disclosed |
| EP-3405517-B1 | ORGANIC POLYMER AEROGELS COMPRISING MICROSTRUCTURES | BLUESHIFT MAT INC (US) | 2021-11-10 | — | — | EP | disclosed |
| US-5413924-A | For use in various in vitro chemical, biochemical and immunological reactions | KOSAK KENNETH M (US) | 1995-05-09 | — | — | US | disclosed |
| EP-0626017-A1 | HEAT-RELEASABLE REAGENTS FOR $i(IN VITRO) CHEMICAL REACTIONS | KOSAK, Kenneth M. (US) | 1994-11-30 | — | — | EP | disclosed |
| EP-0617325-A1 | Method of processing originating photographic elements containing tabular silver chloride grains bounded by (100) faces | EASTMAN KODAK COMPANY (US) | 1994-09-28 | — | — | EP | disclosed |
| WO-1993016200-A1 | HEAT-RELEASABLE REAGENTS FOR IN VITRO CHEMICAL REACTIONS | KOSAK KENNETH M (US) | 1993-08-19 | — | — | WO | disclosed |
| US-4454224-A | CONTAINING PEROXY COMPOUND, BUFFER, AND POLYACETIC ACID | EASTMAN KODAK COMPANY (US) | 1984-06-12 | — | — | US | disclosed |
| US-4015057-A | WITH AN ALIPHATIC CARBOXYLIC ACID | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CYP2C19 1490/4885CYP2D6 1222/4885HIF1A 4440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.